This site is intended for healthcare professionals only
LoginRegister
Ciplas Lanreotide Supply Partners Greece Plant Gets USFDA OAI StatusUSFDA classifies Cipla Goa facility as VAI
Sanofis Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues AlertSanofi Healthcare Gets CDSCO Panel Nod to Study Asthma Drug SAR443765
Intas PharmaIntas Pharmaceutical Gets CDSCO Panels Nod to Conduct Phase III clinical trial of Ruxolitinib cream
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataDoP rejects Glenmark's appeal on price cap of Clotrimazole Cream
Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing PlantLupin to focus on development of inhalers with near-zero global warming potential propellants
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolioMerck, Moderna begin Phase 3 Trial of V940 with Keytruda in non small lung cancer
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIASubmit preclinical data in animal and Phase I CT data: CDSCO Panel Tells IQVIA on Pembrolizumab...
CDSCO Panel Opines Key Changes in Phase III Study of Glimepiride-Linagliptin FDCPure and Cure Healthcare Gets CDSCO Panel Nod To study Pregabalin, Duloxetine, Methylcobalamin FDC
Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCOShockwave Medical concludes enrollment in all-female coronary IVL study
Pfizer, TevaPfizer Wysolone DT price challenge denied: DoP upholds NPPA ceiling on Prednisolone Tablets
Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel DiseaseAbbVie to acquire Aliada Therapeutics for USD 1.4 billion in cash
Emcure to Market Roches CellCept, Mircera, Neorecormon Under New India PactThermo Fisher Scientific, Telangana Govt to establish Bioprocess Design Centre in Hyderabad
X